Filter by: patients
What is Lidocaine Infusion?

Lidocaine is an analgesic, antiarrhythmic agent, and a local anesthetic agent.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Fibromyalgia 3 2 Efficacy_moderate Efficacy_none
Pain 3 2 Efficacy_major Efficacy_moderate
Increase effect of another treatment 2 2 Efficacy_moderate Efficacy_slight
Flank pain 1 1 Efficacy_major
Chronic Pain Syndrome 1 0
Central Pain Syndrome 1 0

See all 4 patients currently taking Lidocaine Infusion

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
3
Mild
3
None
2

Reported Dosages

  30minutes as needed 1 other one time 300 mg monthly 45 min one time
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Lidocaine Infusion (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 2   Did not seem to work: 40%
Expense 1   Expense: 20%
Course of treatment ended 1   Course of treatment ended: 20%
Not indicated 1   Not indicated: 20%

See all 5 patients who’ve stopped taking Lidocaine Infusion

Currently Taking Lidocaine Infusion

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Lidocaine Infusion

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Lidocaine Infusion

Always
5 63%
Usually
1 13%
Sometimes
1 13%
Never
1 13%

Burden

Difficulty being on treatment

Burden of Lidocaine Infusion

Very
2 25%
Somewhat
2 25%
A little
2 25%
Not at all
2 25%

Cost

Paid out of pocket

Cost of Lidocaine Infusion

$200+
0 0%
$100-199
1 13%
$50-99
3 38%
$25-49
1 13%
< $25
3 38%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.